Publication:
May triple therapy still be an alternative to standard therapy in patients with chronic hepatitis C APASL 2015 India

dc.contributor.authorDANALIOĞLU, AHMET
dc.contributor.authorBAYSAL, BİROL
dc.contributor.authorKAYAR, YUSUF
dc.contributor.authorİNCE, ALİ TÜZÜN
dc.contributor.authorŞENTÜRK, HAKAN
dc.contributor.institutionauthorİNCE, ALİ TÜZÜN
dc.contributor.institutionauthorŞENTÜRK, HAKAN
dc.date.accessioned2020-01-16T22:51:30Z
dc.date.available2020-01-16T22:51:30Z
dc.date.issued2015-12-20T00:00:00Z
dc.identifier.citationDANALIOĞLU A., BAYSAL B., KAYAR Y., İNCE A. T. , ŞENTÜRK H., -May triple therapy still be an alternative to standard therapy in patients with chronic hepatitis C APASL 2015 India-, APASL 2015, 18 - 20 Aralık 2015
dc.identifier.urihttps://openaccess.bezmialem.edu.tr/handle/20.500.12645/13357
dc.identifier.yoksis1670185
dc.language.isoen
dc.titleMay triple therapy still be an alternative to standard therapy in patients with chronic hepatitis C APASL 2015 India
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.id3b040cbf-5243-4c9a-89be-46b44c1f6921
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication6daa6ab7-ee45-4f50-9e71-e831046b6462
relation.isAuthorOfPublication278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isAuthorOfPublication.latestForDiscovery278fcf63-3b92-4368-bff6-f140ebd9aeb3
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files